Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum

Jochem B. Buil; Roger J.M. Brüggemann; Roeland E. Wasmann; Jan Zoll; Jacques F. Meis; Willem J.G. Melchers; Johan W. Mouton; Paul E. Verweij

doi:10.1093/jac/dkx425

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum

Jochem B. Buil
, Roger J.M. Brüggemann
, Roeland E. Wasmann
, Jan Zoll
, Jacques F. Meis
, Willem J.G. Melchers
, Johan W. Mouton
, Paul E. Verweij

Group Tissing

Research output: Contribution to journal › Comment/debate

3 Citations (Scopus)

Abstract

In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.

Original language	English
Article number	dkx425
Pages (from-to)	263
Number of pages	1
Journal	Journal of Antimicrobial Chemotherapy
Volume	73
Issue number	1
DOIs	https://doi.org/10.1093/jac/dkx425
Publication status	Published - 1 Jan 2018

Access to Document

10.1093/jac/dkx425

Cite this

Buil, J. B., Brüggemann, R. J. M., Wasmann, R. E., Zoll, J., Meis, J. F., Melchers, W. J. G., Mouton, J. W., & Verweij, P. E. (2018). Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum. Journal of Antimicrobial Chemotherapy, 73(1), 263. Article dkx425. https://doi.org/10.1093/jac/dkx425

@article{d10a1dae96744d9099edc02b99d2cd58,

title = "Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum",

abstract = "In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.",

author = "Buil, \{Jochem B.\} and Br{\"u}ggemann, \{Roger J.M.\} and Wasmann, \{Roeland E.\} and Jan Zoll and Meis, \{Jacques F.\} and Melchers, \{Willem J.G.\} and Mouton, \{Johan W.\} and Verweij, \{Paul E.\}",

year = "2018",

month = jan,

day = "1",

doi = "10.1093/jac/dkx425",

language = "English",

volume = "73",

pages = "263",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "1",

}

Buil, JB, Brüggemann, RJM, Wasmann, RE, Zoll, J, Meis, JF, Melchers, WJG, Mouton, JW & Verweij, PE 2018, 'Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum', Journal of Antimicrobial Chemotherapy, vol. 73, no. 1, dkx425, pp. 263. https://doi.org/10.1093/jac/dkx425

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum. / Buil, Jochem B.; Brüggemann, Roger J.M.; Wasmann, Roeland E. et al.
In: Journal of Antimicrobial Chemotherapy, Vol. 73, No. 1, dkx425, 01.01.2018, p. 263.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs

T2 - Erratum

AU - Buil, Jochem B.

AU - Brüggemann, Roger J.M.

AU - Wasmann, Roeland E.

AU - Zoll, Jan

AU - Meis, Jacques F.

AU - Melchers, Willem J.G.

AU - Mouton, Johan W.

AU - Verweij, Paul E.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.

AB - In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.

UR - https://www.scopus.com/pages/publications/85040554974

U2 - 10.1093/jac/dkx425

DO - 10.1093/jac/dkx425

M3 - Comment/debate

C2 - 29112717

AN - SCOPUS:85040554974

SN - 0305-7453

VL - 73

SP - 263

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 1

M1 - dkx425

ER -

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum

Abstract

Access to Document

Fingerprint

Cite this